Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Numans (2530.HK)
Shanghai, CN
Numans Health Food Holdings Company Limited focuses on the marketing, sale, and distribution of its Nemans-branded nutritional supplements across the People's Republic of China. Their extensive product range features algal oil docosahexaenoic acid (DHA), which supports brain and eye development in infants and children, and helps alleviate forgetfulness, anxiety, and postpartum depression in mothers. The company also offers probiotics, including solid drinks and lactic acid bacteria powders, to improve digestion and boost immunity for all ages. Other offerings include various vitamin and multi-nutrient products specifically formulated for pregnant women, infants, and children, as well as algal calcium and milk powders for diverse age groups. These products are distributed to consumers through both online platforms and traditional retail outlets. Established in Shanghai in 2002, Numans is a wholly-owned subsidiary of Far-East Fortune Management (China) Co., Ltd.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.94% | +7.69% | +18.64% | +16.67% | +20.69% | +12.90% | +11.11% | +1.45% | +1.45% | +1.45% | +1.45% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Packaged Foods: +4.4%-33.5% Q4'25: -62.7% (vs Q4'23)
-
EPS growth Packaged Foods: +14.6%-92.8% Q4'25: -96.3% (vs Q4'23)
-
FCF margin FCF growth · Packaged Foods: +15.9%+13.2% Q4'25: +33.4% (vs Q4'23)
-
EBIT margin Packaged Foods: +7.9%+5.2% Q4'25: +2.5% (vs Q4'23)
-
ROIC Packaged Foods: +7.0%+5.9% Q4'25: +5.9% (vs Q4'23)
-
Share dilution Packaged Foods: +0.0%-0.7% ★ Q4'25: -0.2% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Packaged Foods: 0.19×0.27× ★ Q4'25: 0.21× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-21 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 2/5 | 3/5 | 4/5 | 1/5 | 4/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 2/5 | 3/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-12 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-07 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-06 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-05 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-04 | B+ | 3/5 | 1/5 | 3/5 | 4/5 | 3/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Ping Wang | Chairman & Chief Executive Officer | 931.7K | male |
| Juan Cui | Executive Director | 507.3K | female |
| King Tong Cheng | Company Secretary & Financial Controller | — | male |
| Mei Sun | Financial manager | — | female |
| Kan Wang | Head of external trade | — | male |
| Yao Meng | Head of Legal Department | — | female |
| Ying Gu | Head of Customer Service | — | female |
| Yong An | General manager | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2530.HK
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
